Semaglutide Boosts Heart Health in New Study
Groundbreaking research from Pune reveals diabetes drug semaglutide significantly reduces cardiovascular risks in non-diabetic patients, offering dual benefits for weight and heart health.
Groundbreaking research from Pune reveals diabetes drug semaglutide significantly reduces cardiovascular risks in non-diabetic patients, offering dual benefits for weight and heart health.
Critical medication alert: Major pharmaceutical recall announced after FDA testing reveals cholesterol-lowering pills may not dissolve properly, potentially compromising effectiveness.
In a groundbreaking move, Eli Lilly partners with Cipla to dramatically expand availability of innovative weight loss therapies across India, addressing the growing obesity crisis.
Pharma giant Eli Lilly collaborates with Indian partner Cipla to introduce groundbreaking obesity and diabetes treatments Mounjaro and Yurpeak in the Indian market, expanding access to innovative weight management solutions.
Discover why traditional Indian foods like roti are being wrongly targeted for health problems, and what the real dietary culprits are in modern Indian diets.
Groundbreaking research exposes significant differences in antidepressant side effects. Discover which medications ranked best and worst for safety profiles in this comprehensive analysis.
Neurologist warns about unexpected side effects of common blood pressure and diabetes medications in older adults. Learn the signs and when to consult your doctor.
Expert reveals surprising truths about uterine fibroids - from when they're harmless to when they need treatment. Don't believe these common misconceptions!
Debunking dangerous fitness myths for new mothers - learn what's safe, what's not, and how to properly reclaim your body after delivery.
Are you falling for these common breast cancer misconceptions? Experts reveal the truth about genetic risks, self-exams, and age factors that every millennial needs to know.